English
Find a Study Now
Welcome to the future of
clinical research recruitment

Receive The Newest Study Notifications

Select Page

Study Scavenger Clinical Trial Platform

ICON Early Phase Service Clinical trial study for healthy non-smoking males and females ages 18-55 in San Antonio, TX

Click to call Clinic

ICON Early Phase Services is conducting a research study for healthy non-smoking males and females ages 18-55. The purpose of this study is to test the safety and tolerability of an investigational study drug. The study drug is being developed for sickle cell disease and will be given orally.

 

Phase: I

Health Conditions: Healthy Volunteers Studies

Reference #: GL 3507-0059

Sponsored by: ICON Early Phase Services
Stipend: $9,000
Length of Study:  15 Weeks

Additional Qualifying Information / Important Inclusions or Exclusions: 

Gender: Both
Age: 18 – 55
In-patient or stay overnight at the research centre? Yes

To determine if you fully qualify, it will be necessary to obtain blood samples after an 8- hour fast. You have the option of fasting for the screening appointment, or, you may return later. For more information, see below.

Qualified participants may be compensated up to $9,000 for time and travel. Partial stipend payment available.

If you are able to answer “YES” to the following statements, you may qualify for this study.

  • I am a healthy non-smoking male or female (non-childbearing), meaning no significant medical conditions
  • I am between 18 and 55 years old
  • My BMI is between 18.0 and 30.0 kg/m2 and I weigh at least 110 pounds
  • I have not received treatment with an investigational drug within 30 days (or 5 half-lives) prior to screening or currently participating in another trial of an investigational drug or medical device
  • If Female, I am non-childbearing and meet one of the following criteria- postmenopausal or surgically sterile (bilateral tubal ligation, bilateral salpingectomy, bilateral oophorectomy and/or hysterectomy) – Documentation required.

 

If Male, I agree to refrain from sperm donation and use an effective method of contraception (with partner of childbearing potential) for the duration of the study and for 120 days after the last dose of study drug such as

  • Male condom with spermicide used with highly effective female contraceptive method ( IUD, intrauterine system or hormonal method of contraception such as oral, injected, implanted, or transdermal)
  • Sexual abstinence (no sexual intercourse)
  • vasectomy
  • I have suitable veins for multiple blood samples
  • I am able to communicate effectively in English with the study personnel

ICON Early Phase Services

8307 Gault Ln, San Antonio, TX 78209, USA

Click to call Clinic

ICON Early Phase Service

Study Scavenger Provides the Below Helpful Information

In-Patient/Out-Patient Explained

There are two main reasons clinical research trials are done in an isolated inpatient setting where the patient stays overnight at a research clinic: 1) To protect the study participant:   Some study agents, usually challenge products, can make some people quite sick.  Study participants stay on the inpatient unit to receive 24 hour nursing care during these types of studies. Participants stay on the isolation unit until their laboratory test show they are no longer shedding the infectious agent.  2) To protect the public:  An infectious study agent that is given to a study participant may be harmful to the general public’s health.  Therefore, study participants stay on the inpatient unit until the possibility of giving the infection to someone else has passed.

An outpatient vaccine trial is a study that does not require an overnight stay in the hospital or research clinic.  Participants are given an investigational agent and have scheduled clinic visits to monitor how well they tolerate the investigational agent. Most studies require the clinic staff to follow up with subjects on a daily, weekly or monthly schedule.  Clinic visits can range from 2 to 4 hours, depending on the study and the type of visit.  –  National Institute of Health

Screening Visit

Screening Visit:  Potential candidates for a Study will participate in an initial screening visit to determine if they are appropriate for the Study.  When you first attend the screening visit for phases I-III, the study is explained in detail and you can ask any questions. If you decide to participate, the study nurse will review the informed consent form with you and ask for your signature and permission to proceed with the screening evaluations. –  –  National Institute of Health

Washout Period Explained

A period during a clinical trial when the trial subjects receive no active medication. The wash-out period is typically used to generate patient baseline data.   Every clinic has a washout period during which you are not allowed to do a study at the same clinic or any other clinic.

The minimum period is 30 days since last dose, however some washouts go based on last study procedure (such as out patient visits or how much blood you gave during the study).   The washout period may vary from study to study depending on the half-life of the drug. Certain studies like radio-labeled drugs will have a 1 year washout before you can do another radio-labeled drug.   In addition to the clinic’s washout policy, the sponsor may impose a longer washout period.  Some studies will have a longer washout before you can sign up.

In general, you can sign up and screen for another study during the washout period as long as the check in date is at least 30 days after your last dose in the previous study.  However, depending on how fast your body recovers from a study, you may want to wait the full period to avoid problems with screening.

People who screen too soon after a study typically have lower red blood cell, hemoglobin, hematocritand iron.  If these levels are too low, you could get banned from participating in studies because having low levels is unhealthy and unsafe for participating in a study.

Be forewarned that many clinic participate in the VCT (Verified Clinical Trials) program which tracks when you do a study to ensure the next study meets washout periods.  I do not mention these clinics because it shouldn’t matter.  You know the rules and if you break them, the consequences can be dire like being banned from a clinic.  Sometimes the only way to drive this message home is to allow people to find out the hard way. –  –  National Institute of Health

SEARCH FOR STUDIES